HIGHLIGHTS
- who: Encan Li and colleagues from the Department of Medical Physiology, Division of Heart and Lungs, University Medical Center Utrecht, Yalelaan, CM Utrecht, The Netherlands have published the research: Chronic Propafenone Application Increases Functional KIR2.1 Expression In Vitro, in the Journal: Pharmaceuticals 2023, 16, 404. of /2023/
- what: This study provides a basis for further research on propafenone-based AgoKirs, thus contributing to the development of a therapy for diseases in which the function of KIR 2.1 is reduced.
- how: The results showed that the expression of KIR 2.1 channel . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.